Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 26, 2021; 9(30): 9070-9076
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9070
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9070
Measure | Observation group, n = 40 | Control group, n = 460 | t/χ2 value | P value |
Sex (Male/Female) | 23/17 | 287/173 | 1.230 | 0.154 |
Age in yr (mean ± SD) | 76.21 ± 10.33 | 75.87 ± 10.08 | 0.922 | 0.346 |
History of hypertension (Yes/No) | 25/15 | 249/211 | 2.221 | 0.098 |
History of diabetes (Yes/No) | 13/27 | 142/318 | 1.255 | 0.123 |
History of atrial fibrillation (Yes/No) | 14/26 | 115/345 | 1.873 | 0.101 |
History of cerebrovascular diseases (Yes/No) | 11/29 | 83/377 | 0.812 | 0.401 |
History of smoking (Yes/No) | 21/19 | 253/207 | 2.437 | 0.086 |
History of alcohol consumption (Yes/No) | 18/22 | 193/267 | 1.167 | 0.172 |
NHISS score (mean ± SD) | 15.21 ± 2.18 | 11.42 ± 2.65 | 17.321 | 0.001 |
- Citation: Zhong TT, Wang G, Wang XQ, Kong WD, Li XY, Xue Q, Zou YA. Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients. World J Clin Cases 2021; 9(30): 9070-9076
- URL: https://www.wjgnet.com/2307-8960/full/v9/i30/9070.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i30.9070